SJP was founded in 1975 by two businessmen who had a vision to provide quality and affordable drugs for common ailments within the general population. With an initial focus on respiratory drugs, more commonly known as the cough-and-cold category, their vision has evolved through the decades to include urology and cardiovascular drugs. The legacy of two aspiring entrepreneurs has now been passed to the second generation, which has the experience and determination to continue SJP’s quest to be the company that sets the bar for specialty pharma.

With sales representatives in the Southeast and Texas, SJP has direct coverage in 10 states and extended indirect reach in various states throughout the U.S. SJP is strategically positioned for rapid yet controlled growth, both in terms of its sales force and product portfolio.